Skip to main content

Game-changing uPAR-targeting dye for guiding surgical treatment of cancer

Deliverables

Publication of initial clinical result

Publication of initial clinical result

Publication of clinical trial metrology

Publication of clinical trial metrology

Searching for OpenAIRE data...

Publications

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts

Author(s): Sorel Kurbegovic, Karina Juhl, Kasper Kildegaard Sørensen, Julie Leth, Gro Linno Willemoe, Anders Christensen, Yvonne Adams, Anja Ramstedt Jensen, Christian von Buchwald, Jane Skjøth-Rasmussen, Michael Ploug, Knud J. Jensen, Andreas Kjaer
Published in: Theranostics, 11/15, 2021, Page(s) 7159-7174, ISSN 1838-7640
Publisher: Ivyspring International Publisher
DOI: 10.7150/thno.49787

Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial

Author(s): Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso, Andreas Kjaer
Published in: Journal of Nuclear Medicine, 62/3, 2021, Page(s) 354-359, ISSN 0161-5505
Publisher: Kexue Chubaneshe/Science Press
DOI: 10.2967/jnumed.120.248120